

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.14634174 |
| 2 | regulation of synapse structural plasticity (GO:0051823) | 5.83824898 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.69858525 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.63362339 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.54139031 |
| 6 | synaptic transmission, dopaminergic (GO:0001963) | 5.48401396 |
| 7 | prepulse inhibition (GO:0060134) | 5.45167718 |
| 8 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.25350651 |
| 9 | vocalization behavior (GO:0071625) | 5.24229830 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.15269269 |
| 11 | adenosine receptor signaling pathway (GO:0001973) | 4.95792211 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.94742919 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.93370165 |
| 14 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.85695206 |
| 15 | striatum development (GO:0021756) | 4.71095436 |
| 16 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.67503524 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.65032427 |
| 18 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.59874962 |
| 19 | synaptic vesicle exocytosis (GO:0016079) | 4.59354820 |
| 20 | response to amphetamine (GO:0001975) | 4.53456146 |
| 21 | dendritic spine morphogenesis (GO:0060997) | 4.53182075 |
| 22 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.51558632 |
| 23 | auditory behavior (GO:0031223) | 4.50030080 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.46567924 |
| 25 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.41813271 |
| 26 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.39327295 |
| 27 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.38575241 |
| 28 | positive regulation of neurotransmitter transport (GO:0051590) | 4.34126073 |
| 29 | protein localization to synapse (GO:0035418) | 4.29780758 |
| 30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.29182284 |
| 31 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.26074444 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.21537098 |
| 33 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.19822599 |
| 34 | dopamine receptor signaling pathway (GO:0007212) | 4.19039202 |
| 35 | neuromuscular process controlling balance (GO:0050885) | 4.18006895 |
| 36 | regulation of female receptivity (GO:0045924) | 4.17730019 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 4.17357227 |
| 38 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.17112100 |
| 39 | regulation of glutamate secretion (GO:0014048) | 4.15546165 |
| 40 | behavioral response to cocaine (GO:0048148) | 4.14866310 |
| 41 | exploration behavior (GO:0035640) | 4.13345911 |
| 42 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.06995503 |
| 43 | long-term memory (GO:0007616) | 4.05649385 |
| 44 | positive regulation of membrane potential (GO:0045838) | 4.04867986 |
| 45 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.03431921 |
| 46 | synaptic transmission, glutamatergic (GO:0035249) | 4.02891459 |
| 47 | neurotransmitter secretion (GO:0007269) | 4.00066256 |
| 48 | glutamate receptor signaling pathway (GO:0007215) | 3.95583527 |
| 49 | response to auditory stimulus (GO:0010996) | 3.92214991 |
| 50 | regulation of synaptic plasticity (GO:0048167) | 3.88760056 |
| 51 | regulation of postsynaptic membrane potential (GO:0060078) | 3.86893442 |
| 52 | regulation of synaptic vesicle transport (GO:1902803) | 3.86033063 |
| 53 | neuronal action potential propagation (GO:0019227) | 3.85932338 |
| 54 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.81090349 |
| 55 | cAMP catabolic process (GO:0006198) | 3.80884484 |
| 56 | glutamate secretion (GO:0014047) | 3.78336065 |
| 57 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.77190910 |
| 58 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.77190910 |
| 59 | layer formation in cerebral cortex (GO:0021819) | 3.74023403 |
| 60 | behavioral defense response (GO:0002209) | 3.72787067 |
| 61 | behavioral fear response (GO:0001662) | 3.72787067 |
| 62 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.72702384 |
| 63 | neuronal ion channel clustering (GO:0045161) | 3.67828212 |
| 64 | female mating behavior (GO:0060180) | 3.67495475 |
| 65 | transmission of nerve impulse (GO:0019226) | 3.66673017 |
| 66 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.65925484 |
| 67 | long-term synaptic potentiation (GO:0060291) | 3.65342085 |
| 68 | regulation of dendritic spine development (GO:0060998) | 3.61519606 |
| 69 | response to histamine (GO:0034776) | 3.57977926 |
| 70 | visual learning (GO:0008542) | 3.54361614 |
| 71 | activation of protein kinase A activity (GO:0034199) | 3.53602136 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 3.51830359 |
| 73 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.51339961 |
| 74 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.51339961 |
| 75 | negative regulation of dendrite development (GO:2000171) | 3.49416194 |
| 76 | negative regulation of amino acid transport (GO:0051956) | 3.44930358 |
| 77 | dendritic spine organization (GO:0097061) | 3.44721839 |
| 78 | regulation of neurotransmitter uptake (GO:0051580) | 3.43265572 |
| 79 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.39978946 |
| 80 | neuron cell-cell adhesion (GO:0007158) | 3.37727414 |
| 81 | mechanosensory behavior (GO:0007638) | 3.35849973 |
| 82 | visual behavior (GO:0007632) | 3.34605002 |
| 83 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.33955664 |
| 84 | fear response (GO:0042596) | 3.33422585 |
| 85 | learning (GO:0007612) | 3.33301880 |
| 86 | cyclic nucleotide catabolic process (GO:0009214) | 3.31180947 |
| 87 | membrane hyperpolarization (GO:0060081) | 3.30430903 |
| 88 | cAMP metabolic process (GO:0046058) | 3.29780924 |
| 89 | glycine transport (GO:0015816) | 3.27489611 |
| 90 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.22895767 |
| 91 | membrane depolarization (GO:0051899) | 3.22694281 |
| 92 | positive regulation of synaptic transmission (GO:0050806) | 3.22324460 |
| 93 | positive regulation of dendritic spine development (GO:0060999) | 3.21139056 |
| 94 | regulation of protein kinase A signaling (GO:0010738) | 3.20412524 |
| 95 | mating behavior (GO:0007617) | 3.15730423 |
| 96 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.14786000 |
| 97 | response to amine (GO:0014075) | 3.12915030 |
| 98 | neuromuscular process (GO:0050905) | 3.12496220 |
| 99 | cAMP biosynthetic process (GO:0006171) | 3.12059131 |
| 100 | cellular potassium ion homeostasis (GO:0030007) | 3.11615458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.43188961 |
| 2 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 4.00896255 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21796436 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16752430 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.12419260 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.04189477 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.01012910 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.82178657 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.82178657 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.80909989 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.79335295 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74541109 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72543103 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.67213377 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.64299799 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.61853365 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.51623495 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48893937 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.42502056 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.38927572 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35579021 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.32876301 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26861528 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.26836933 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03593376 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.96655500 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88322584 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88260191 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.69274272 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61667244 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.54295978 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47340147 |
| 33 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41353094 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40502117 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37971657 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37958830 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.37248092 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36700763 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35503603 |
| 40 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.34546206 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34140857 |
| 42 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33556193 |
| 43 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.30346867 |
| 44 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.29637487 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27892839 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26513731 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26399845 |
| 48 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25904829 |
| 49 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.22830413 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19864861 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19496715 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18444947 |
| 53 | AR_19668381_ChIP-Seq_PC3_Human | 1.17333992 |
| 54 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16040752 |
| 55 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15290070 |
| 56 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14574708 |
| 57 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11868594 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10410633 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09203076 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09073129 |
| 61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07082658 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.06497573 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05874773 |
| 64 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05149101 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03626042 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00979866 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00349464 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 0.99586317 |
| 69 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98261863 |
| 70 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97478488 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96498490 |
| 72 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.95255597 |
| 73 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.93396599 |
| 74 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92543064 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91813318 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91701752 |
| 77 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91294653 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91140756 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90158267 |
| 80 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89915926 |
| 81 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.89085377 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88790247 |
| 83 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88377512 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88291508 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88072459 |
| 86 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87577811 |
| 87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86970871 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85621457 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85473238 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85429554 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85250601 |
| 92 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.85214077 |
| 93 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85003657 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84842530 |
| 95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83584979 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82593385 |
| 97 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79656695 |
| 98 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.78801001 |
| 99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.78640047 |
| 100 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77184134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 7.96334876 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 6.85264849 |
| 3 | MP0003880_abnormal_central_pattern | 4.44790743 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.28361620 |
| 5 | MP0009745_abnormal_behavioral_response | 3.83442488 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.62630704 |
| 7 | MP0004270_analgesia | 3.48920625 |
| 8 | MP0002064_seizures | 3.09239963 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.88377871 |
| 10 | MP0001486_abnormal_startle_reflex | 2.72640826 |
| 11 | MP0009046_muscle_twitch | 2.69877461 |
| 12 | MP0001529_abnormal_vocalization | 2.66634421 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.62110926 |
| 14 | MP0002272_abnormal_nervous_system | 2.52469256 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.37838210 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.28000684 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.22723172 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.03881296 |
| 19 | MP0005646_abnormal_pituitary_gland | 1.96629981 |
| 20 | MP0004924_abnormal_behavior | 1.89150403 |
| 21 | MP0005386_behavior/neurological_phenoty | 1.89150403 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.88462272 |
| 23 | MP0002736_abnormal_nociception_after | 1.86434485 |
| 24 | MP0005409_darkened_coat_color | 1.82184710 |
| 25 | MP0001970_abnormal_pain_threshold | 1.76835765 |
| 26 | MP0004811_abnormal_neuron_physiology | 1.68679984 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.68489440 |
| 28 | MP0001440_abnormal_grooming_behavior | 1.67854692 |
| 29 | MP0008569_lethality_at_weaning | 1.66698555 |
| 30 | MP0001984_abnormal_olfaction | 1.65410803 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.64530995 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.59585338 |
| 33 | MP0003075_altered_response_to | 1.56839099 |
| 34 | MP0003879_abnormal_hair_cell | 1.56484513 |
| 35 | MP0003329_amyloid_beta_deposits | 1.48692113 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.47280792 |
| 37 | MP0001188_hyperpigmentation | 1.43717894 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.39624833 |
| 39 | MP0008874_decreased_physiological_sensi | 1.36616425 |
| 40 | MP0003633_abnormal_nervous_system | 1.34417046 |
| 41 | MP0004885_abnormal_endolymph | 1.33512329 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.33267549 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.28271074 |
| 44 | MP0001905_abnormal_dopamine_level | 1.27587823 |
| 45 | MP0008872_abnormal_physiological_respon | 1.26109690 |
| 46 | MP0002184_abnormal_innervation | 1.25735960 |
| 47 | MP0000955_abnormal_spinal_cord | 1.20361921 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.18250471 |
| 49 | MP0001177_atelectasis | 1.15842913 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.11741735 |
| 51 | MP0004858_abnormal_nervous_system | 1.10036823 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.08711492 |
| 53 | MP0000778_abnormal_nervous_system | 1.08204202 |
| 54 | MP0003631_nervous_system_phenotype | 1.04106417 |
| 55 | MP0004085_abnormal_heartbeat | 1.03684426 |
| 56 | MP0003283_abnormal_digestive_organ | 0.97668093 |
| 57 | MP0003787_abnormal_imprinting | 0.96951265 |
| 58 | MP0001502_abnormal_circadian_rhythm | 0.96879696 |
| 59 | MP0005535_abnormal_body_temperature | 0.95373247 |
| 60 | MP0002069_abnormal_eating/drinking_beha | 0.95030983 |
| 61 | MP0000751_myopathy | 0.93701621 |
| 62 | MP0003690_abnormal_glial_cell | 0.90572023 |
| 63 | MP0002152_abnormal_brain_morphology | 0.88206100 |
| 64 | MP0000920_abnormal_myelination | 0.84638860 |
| 65 | MP0002090_abnormal_vision | 0.83320658 |
| 66 | MP0004142_abnormal_muscle_tone | 0.82765880 |
| 67 | MP0000569_abnormal_digit_pigmentation | 0.79085533 |
| 68 | MP0003137_abnormal_impulse_conducting | 0.71275092 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 0.70434745 |
| 70 | MP0005394_taste/olfaction_phenotype | 0.70395060 |
| 71 | MP0005499_abnormal_olfactory_system | 0.70395060 |
| 72 | MP0002229_neurodegeneration | 0.69262673 |
| 73 | MP0005166_decreased_susceptibility_to | 0.69221140 |
| 74 | MP0000604_amyloidosis | 0.65262759 |
| 75 | MP0003634_abnormal_glial_cell | 0.61458447 |
| 76 | MP0001664_abnormal_digestion | 0.60940741 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 0.57781243 |
| 78 | MP0006276_abnormal_autonomic_nervous | 0.55477321 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.55067660 |
| 80 | MP0001485_abnormal_pinna_reflex | 0.55059072 |
| 81 | MP0003632_abnormal_nervous_system | 0.54541317 |
| 82 | MP0004510_myositis | 0.54114227 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.48786194 |
| 84 | MP0004215_abnormal_myocardial_fiber | 0.48366221 |
| 85 | MP0005620_abnormal_muscle_contractility | 0.48118775 |
| 86 | MP0001943_abnormal_respiration | 0.46573097 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.45437653 |
| 88 | MP0003956_abnormal_body_size | 0.44225406 |
| 89 | MP0004484_altered_response_of | 0.43725391 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.43470188 |
| 91 | MP0003303_peritoneal_inflammation | 0.42599419 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.41893100 |
| 93 | MP0004742_abnormal_vestibular_system | 0.41870339 |
| 94 | MP0004043_abnormal_pH_regulation | 0.41734057 |
| 95 | MP0005623_abnormal_meninges_morphology | 0.41482066 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.39808534 |
| 97 | MP0010769_abnormal_survival | 0.39524437 |
| 98 | MP0004130_abnormal_muscle_cell | 0.39331991 |
| 99 | MP0002234_abnormal_pharynx_morphology | 0.39002715 |
| 100 | MP0004036_abnormal_muscle_relaxation | 0.38906895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.38520963 |
| 2 | Focal motor seizures (HP:0011153) | 7.96179894 |
| 3 | Focal seizures (HP:0007359) | 5.95485529 |
| 4 | Visual hallucinations (HP:0002367) | 4.67839788 |
| 5 | Annular pancreas (HP:0001734) | 4.51028092 |
| 6 | Torticollis (HP:0000473) | 4.17168757 |
| 7 | Poor eye contact (HP:0000817) | 4.16112694 |
| 8 | Resting tremor (HP:0002322) | 4.12931395 |
| 9 | Anxiety (HP:0000739) | 4.01341852 |
| 10 | Action tremor (HP:0002345) | 3.96907533 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.89300518 |
| 12 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.85870651 |
| 13 | Depression (HP:0000716) | 3.75708597 |
| 14 | Broad-based gait (HP:0002136) | 3.71665549 |
| 15 | Impaired social interactions (HP:0000735) | 3.71338608 |
| 16 | Abnormal social behavior (HP:0012433) | 3.71338608 |
| 17 | Focal dystonia (HP:0004373) | 3.69179137 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 3.62209872 |
| 19 | Ankle clonus (HP:0011448) | 3.56824915 |
| 20 | Craniofacial dystonia (HP:0012179) | 3.52391565 |
| 21 | Absence seizures (HP:0002121) | 3.50676112 |
| 22 | Ankyloglossia (HP:0010296) | 3.49979726 |
| 23 | Febrile seizures (HP:0002373) | 3.47456707 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.40268591 |
| 25 | Dialeptic seizures (HP:0011146) | 3.35568177 |
| 26 | Atonic seizures (HP:0010819) | 3.25079681 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 3.21145100 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.19357281 |
| 29 | Papilledema (HP:0001085) | 3.16981914 |
| 30 | Dysmetria (HP:0001310) | 3.15230718 |
| 31 | Stereotypic behavior (HP:0000733) | 3.11873864 |
| 32 | Postural instability (HP:0002172) | 3.07005745 |
| 33 | Pointed chin (HP:0000307) | 3.05691040 |
| 34 | Lower limb amyotrophy (HP:0007210) | 3.03552887 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 2.97653691 |
| 36 | Amblyopia (HP:0000646) | 2.91443169 |
| 37 | Urinary urgency (HP:0000012) | 2.90549408 |
| 38 | Progressive cerebellar ataxia (HP:0002073) | 2.89747750 |
| 39 | Dysmetric saccades (HP:0000641) | 2.86150712 |
| 40 | Truncal ataxia (HP:0002078) | 2.82065928 |
| 41 | Hyperventilation (HP:0002883) | 2.79515609 |
| 42 | Prolonged QT interval (HP:0001657) | 2.71392618 |
| 43 | Abnormal eating behavior (HP:0100738) | 2.66624616 |
| 44 | Intention tremor (HP:0002080) | 2.66453689 |
| 45 | Scanning speech (HP:0002168) | 2.65918633 |
| 46 | Polygenic inheritance (HP:0010982) | 2.65745823 |
| 47 | Abnormality of the lower motor neuron (HP:0002366) | 2.63838768 |
| 48 | Abnormality of oral frenula (HP:0000190) | 2.63268471 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.62536303 |
| 50 | Bradykinesia (HP:0002067) | 2.60490787 |
| 51 | Impaired vibratory sensation (HP:0002495) | 2.60326900 |
| 52 | Abnormal EKG (HP:0003115) | 2.58692319 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 2.53614476 |
| 54 | Spastic gait (HP:0002064) | 2.52242011 |
| 55 | Megalencephaly (HP:0001355) | 2.49934427 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.42412846 |
| 57 | Mutism (HP:0002300) | 2.41310405 |
| 58 | Neurofibrillary tangles (HP:0002185) | 2.40372822 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.40371454 |
| 60 | Atrioventricular block (HP:0001678) | 2.35149324 |
| 61 | Lower limb asymmetry (HP:0100559) | 2.31995297 |
| 62 | Status epilepticus (HP:0002133) | 2.28139550 |
| 63 | Incomplete penetrance (HP:0003829) | 2.23908667 |
| 64 | Progressive inability to walk (HP:0002505) | 2.23650514 |
| 65 | Hemiparesis (HP:0001269) | 2.23529043 |
| 66 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.21939402 |
| 67 | Truncus arteriosus (HP:0001660) | 2.15116291 |
| 68 | Clonus (HP:0002169) | 2.13969254 |
| 69 | Heart block (HP:0012722) | 2.11505958 |
| 70 | Bundle branch block (HP:0011710) | 2.11364510 |
| 71 | Hemiplegia (HP:0002301) | 2.10986130 |
| 72 | Obstructive sleep apnea (HP:0002870) | 2.10883669 |
| 73 | Distal upper limb amyotrophy (HP:0007149) | 2.09478175 |
| 74 | Upper limb amyotrophy (HP:0009129) | 2.09478175 |
| 75 | Limb dystonia (HP:0002451) | 2.07735318 |
| 76 | Excessive salivation (HP:0003781) | 2.07227714 |
| 77 | Drooling (HP:0002307) | 2.07227714 |
| 78 | Neuronal loss in central nervous system (HP:0002529) | 2.06065990 |
| 79 | Lower limb muscle weakness (HP:0007340) | 2.05235207 |
| 80 | Insidious onset (HP:0003587) | 2.01057806 |
| 81 | Termporal pattern (HP:0011008) | 2.01057806 |
| 82 | Insomnia (HP:0100785) | 1.97103243 |
| 83 | Epileptiform EEG discharges (HP:0011182) | 1.97020030 |
| 84 | Abnormality of the periventricular white matter (HP:0002518) | 1.94786945 |
| 85 | Absent speech (HP:0001344) | 1.90517003 |
| 86 | Abnormal atrioventricular conduction (HP:0005150) | 1.89872223 |
| 87 | Deep palmar crease (HP:0006191) | 1.87918842 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 1.86806469 |
| 89 | Genetic anticipation (HP:0003743) | 1.85680830 |
| 90 | Limb hypertonia (HP:0002509) | 1.83159235 |
| 91 | Abnormality of saccadic eye movements (HP:0000570) | 1.82894624 |
| 92 | Spinal canal stenosis (HP:0003416) | 1.82235903 |
| 93 | Diplopia (HP:0000651) | 1.82169349 |
| 94 | Abnormality of binocular vision (HP:0011514) | 1.82169349 |
| 95 | Deeply set eye (HP:0000490) | 1.81829716 |
| 96 | Hypsarrhythmia (HP:0002521) | 1.81777460 |
| 97 | Bowel incontinence (HP:0002607) | 1.81603903 |
| 98 | Axonal loss (HP:0003447) | 1.80784652 |
| 99 | Gait ataxia (HP:0002066) | 1.80706917 |
| 100 | Primary atrial arrhythmia (HP:0001692) | 1.80548230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 7.92931919 |
| 2 | NTRK3 | 4.08717447 |
| 3 | MAP3K9 | 3.75302642 |
| 4 | RIPK4 | 3.28402364 |
| 5 | KSR2 | 2.82688177 |
| 6 | DAPK2 | 2.73585903 |
| 7 | PRKD3 | 2.56482616 |
| 8 | CAMKK1 | 2.22867479 |
| 9 | MINK1 | 2.15196214 |
| 10 | MAP3K13 | 2.06402604 |
| 11 | ARAF | 2.03447680 |
| 12 | FES | 1.93613073 |
| 13 | MAP3K4 | 1.93575106 |
| 14 | NTRK1 | 1.88414924 |
| 15 | KSR1 | 1.80741803 |
| 16 | PAK6 | 1.70489649 |
| 17 | DAPK1 | 1.69788236 |
| 18 | NTRK2 | 1.66257878 |
| 19 | TAOK1 | 1.61254074 |
| 20 | SIK2 | 1.60523071 |
| 21 | CDK5 | 1.59406360 |
| 22 | MAP2K7 | 1.50909419 |
| 23 | MAP3K2 | 1.39017082 |
| 24 | TYRO3 | 1.38123025 |
| 25 | MARK1 | 1.37997730 |
| 26 | RAF1 | 1.33673639 |
| 27 | BMPR2 | 1.27387521 |
| 28 | TNIK | 1.24498261 |
| 29 | PRPF4B | 1.24494425 |
| 30 | MAP2K4 | 1.21992713 |
| 31 | STK38 | 1.12274831 |
| 32 | CAMKK2 | 1.08079609 |
| 33 | MAP3K12 | 1.06483548 |
| 34 | PINK1 | 1.06098654 |
| 35 | PTK2B | 1.01753583 |
| 36 | MAP3K1 | 0.91961808 |
| 37 | STK11 | 0.90233679 |
| 38 | PRKCG | 0.89995884 |
| 39 | PRKCH | 0.89322073 |
| 40 | GRK5 | 0.86621229 |
| 41 | SGK223 | 0.85136222 |
| 42 | SGK494 | 0.85136222 |
| 43 | PDPK1 | 0.84167335 |
| 44 | PDK1 | 0.83393947 |
| 45 | CDK18 | 0.81689207 |
| 46 | CAMK2A | 0.81674171 |
| 47 | CDK15 | 0.80109224 |
| 48 | CAMK1 | 0.79613849 |
| 49 | SGK1 | 0.79149964 |
| 50 | MARK2 | 0.77442230 |
| 51 | CDK14 | 0.77042775 |
| 52 | ALK | 0.76176032 |
| 53 | CAMK2B | 0.75772109 |
| 54 | UHMK1 | 0.74731356 |
| 55 | RET | 0.74662735 |
| 56 | SGK2 | 0.74135918 |
| 57 | TNK2 | 0.71984364 |
| 58 | CDK19 | 0.70458435 |
| 59 | PLK2 | 0.70244712 |
| 60 | CDK11A | 0.69968435 |
| 61 | SGK3 | 0.69920789 |
| 62 | NEK1 | 0.67212334 |
| 63 | DMPK | 0.66893377 |
| 64 | MAP2K1 | 0.59526011 |
| 65 | TRIB3 | 0.59066215 |
| 66 | PRKD2 | 0.55590314 |
| 67 | MAPK13 | 0.55513668 |
| 68 | RIPK1 | 0.54131356 |
| 69 | FGFR2 | 0.54117349 |
| 70 | MOS | 0.53895123 |
| 71 | DAPK3 | 0.52832803 |
| 72 | FYN | 0.52157525 |
| 73 | PRKCZ | 0.50946420 |
| 74 | RPS6KA3 | 0.50629166 |
| 75 | NEK6 | 0.50515418 |
| 76 | MAPK10 | 0.46423795 |
| 77 | CAMK4 | 0.45811693 |
| 78 | LMTK2 | 0.43152210 |
| 79 | BRAF | 0.41432929 |
| 80 | FGR | 0.40432783 |
| 81 | BRSK1 | 0.38397040 |
| 82 | CASK | 0.38068909 |
| 83 | PNCK | 0.34752575 |
| 84 | MAP3K7 | 0.34126098 |
| 85 | DYRK1A | 0.33746942 |
| 86 | CAMK2D | 0.33619776 |
| 87 | PRKCB | 0.32524219 |
| 88 | WNK1 | 0.31891540 |
| 89 | PAK3 | 0.31691263 |
| 90 | CAMK2G | 0.30967127 |
| 91 | PRKCE | 0.30544820 |
| 92 | PRKCQ | 0.29898086 |
| 93 | HCK | 0.28448533 |
| 94 | MUSK | 0.26311330 |
| 95 | PRKACG | 0.26087730 |
| 96 | PRKCA | 0.25677831 |
| 97 | CSNK1A1 | 0.25623238 |
| 98 | PRKACA | 0.25622149 |
| 99 | FRK | 0.24696782 |
| 100 | CDC42BPA | 0.22016193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.59201643 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.04860191 |
| 3 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.86972674 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.82148017 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.81734476 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79097532 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.65218938 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.61365652 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.57228916 |
| 10 | Cocaine addiction_Homo sapiens_hsa05030 | 2.45792005 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.43169119 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.38738010 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.22064649 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.14630409 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 2.08431931 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.95294435 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94413224 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.88880139 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.82655565 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.77520559 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.76799624 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.75366554 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.60036035 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58723414 |
| 25 | Gap junction_Homo sapiens_hsa04540 | 1.57364200 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.51269852 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.49425568 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48570335 |
| 29 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.42975610 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.33088914 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30701127 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.24654235 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15294213 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14032822 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08473526 |
| 36 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07428928 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03139268 |
| 38 | Melanogenesis_Homo sapiens_hsa04916 | 1.01579706 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98805241 |
| 40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94203313 |
| 41 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91213915 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90832255 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90008239 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88987466 |
| 45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85903438 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85799577 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85785448 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85488457 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84046235 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83470793 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83288598 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 0.81129766 |
| 53 | Alcoholism_Homo sapiens_hsa05034 | 0.80419611 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.80234235 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80179831 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77399756 |
| 57 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77169107 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72952711 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72014318 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70487298 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69241049 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66689920 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65174866 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64249046 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63796650 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63305597 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59755684 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58302500 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57195479 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56921743 |
| 71 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56178408 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54929208 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54394587 |
| 74 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53797351 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.51503081 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50221016 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.48185797 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47640650 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47185423 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46162142 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.45661988 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.44779134 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43065581 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42216369 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41000060 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39564389 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37791245 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37580062 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37380007 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36939366 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35157713 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31744282 |
| 93 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31467241 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30089111 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27920170 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.27260244 |
| 97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.26059225 |
| 98 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25440770 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.25248162 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25082537 |

